HAE Haemonetics Corporation

$102.69▲ +1.61% Healthcare Other
After hours $102.69▲ +0.00% Sep 11, 4:03 PM ET
Volume 458.3K Avg Volume (10D) 598.1K
Key Metrics & Fundamentals
Market Cap
$4.67B
P/E Ratio
49.6
Div Yield
–%
52W Range
47.32 - 109.57
% vs 50 MA
13.14%
% vs 200 MA
38.24%
RSI-14
58.1
MACD Histogram
-1.2100
Beta (1Y vs SPY)
0.11
Free Cash Flow
$44.42M
Gross Rev
$339.38M
Gross Profit
$202.80M
EBITDA
$84.57M
COGS
$136.58M
Operating Exp
$145.35M
Operating Income
$57.46M
EBIT
$57.46M
Pretax Income
$47.57M
Net Income
$33.01M
EPS (Diluted)
0.72
Price & Volume History
Loading chart…
Recent News
GEHC vs. HAE: Which Stock Is the Better Value Option?
Zacks · Aug 31, 2026 3:40 PM
2 Momentum Stocks with Exciting Potential and 1 We Avoid
StockStory · Aug 24, 2026 11:21 AM
Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
StockStory · Aug 21, 2026 7:55 PM
1 Russell 2000 Stock with Competitive Advantages and 2 We Turn Down
StockStory · Aug 20, 2026 2:11 PM
Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating
MT Newswires · Aug 19, 2026 11:34 AM
Sector Update: Healthcare Stocks Climb Late Afternoon
MT Newswires · Aug 18, 2026 7:51 PM
Sector Update: Healthcare
MT Newswires · Aug 18, 2026 7:19 PM
Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma
MT Newswires · Aug 18, 2026 6:40 PM
1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid
StockStory · Aug 17, 2026 7:58 PM
Haemonetics (HAE) Stock Could Be 49% Below Fair Value On Raised Guidance
Simply Wall St. · Aug 16, 2026 2:08 AM
Financial Overview - Income Statement Quarterly

See HAE's money flow as a full page

Social Sentiment
Avg +0.74 · 6 posts
DDNewsDiscussionNTLA beginning to gain serious traction
r/wallstreetbets · Oct 8, 2025
The post discusses a clinical trial (lonvo-z) related to HAE and a positive aspect of the technology (in vivo CRISPR).
positive +0.70
NewsDiscussionIn vivo CRISPR and potentially major catalysts ahead for NTLA
r/investing · Oct 2, 2025
Mention of HAE and its treatment with in vivo CRISPR contributes to the positive sentiment surrounding NTLA's prospects.
positive +0.60
NewsDiscussionIONS is About to Break Out
r/wallstreetbets · Aug 19, 2025
The post focuses on a product related to HAE, indicating positive interest in the broader HAE market.
positive +0.80
NewsTradeDD$KALV ($15.06) KalVista FDA breakout. First oral HAE drug + bullish options setup
r/options · Jul 8, 2025
The post highlights FDA approval, bullish options, and potential price targets indicating strong belief in KALV's future.
positive +0.80
NewsDDTrade[KALV] FDA APPROVED 🚀 | First-in-class oral HAE drug is here — buckle up
r/wallstreetbets · Jul 7, 2025
The post highlights significant positive developments like FDA approval, market exclusivity, and a potential short squeeze, indicating strong bullish sentiment.
positive +0.80
Page 1 of 2 (6 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙